[Lamotrigine (Lamictal)].
Scheen
A J
AJ
Département de Médecine, Université de Liège.
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D004829:Epilepsy, Generalized / Q000188:drug therapy; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D000077213:Lamotrigine; D026941:Sodium Channel Blockers; D014226:Triazenes / Q000037:antagonists & inhibitors; D014227:Triazines / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use
D000927:Anticonvulsants; D004338:Drug Combinations; D018691:Excitatory Amino Acid Antagonists; D026941:Sodium Channel Blockers; D014226:Triazenes; D014227:Triazines; D014635:Valproic Acid; D000077213:Lamotrigine
La lamotrigine (Lamictal).